Tafenoquine Succinate Patent Expiration
Tafenoquine Succinate is used for preventing malaria in adults through a three-phase dosing regimen. It was first introduced by Glaxosmithkline Intellectual Property Development Ltd England
Tafenoquine Succinate Patents
Given below is the list of patents protecting Tafenoquine Succinate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Arakoda | US10342791 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | Dec 02, 2035 | 60 Degrees Pharms |
Arakoda | US10888558 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | Dec 02, 2035 | 60 Degrees Pharms |
Arakoda | US11744828 | Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects | Dec 02, 2035 | 60 Degrees Pharms |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳